[go: up one dir, main page]

WO2004087874A3 - Acides nucleiques et polypeptides - Google Patents

Acides nucleiques et polypeptides Download PDF

Info

Publication number
WO2004087874A3
WO2004087874A3 PCT/US2004/009202 US2004009202W WO2004087874A3 WO 2004087874 A3 WO2004087874 A3 WO 2004087874A3 US 2004009202 W US2004009202 W US 2004009202W WO 2004087874 A3 WO2004087874 A3 WO 2004087874A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
polypeptides
novel nucleic
novel
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2004/009202
Other languages
English (en)
Other versions
WO2004087874A2 (fr
Inventor
Y Tom Tang
Ping Zhou
Jian-Rui Wang
Zhi Wei Wang
Tianhua Hu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of WO2004087874A2 publication Critical patent/WO2004087874A2/fr
Anticipated expiration legal-status Critical
Publication of WO2004087874A3 publication Critical patent/WO2004087874A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne des acides nucléiques, des séquences polypeptidiques codées par ceux-ci et des utilisations de ceux-ci.
PCT/US2004/009202 2003-03-28 2004-03-24 Acides nucleiques et polypeptides Ceased WO2004087874A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45882403P 2003-03-28 2003-03-28
US60/458,824 2003-03-28

Publications (2)

Publication Number Publication Date
WO2004087874A2 WO2004087874A2 (fr) 2004-10-14
WO2004087874A3 true WO2004087874A3 (fr) 2005-12-22

Family

ID=33131831

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/009202 Ceased WO2004087874A2 (fr) 2003-03-28 2004-03-24 Acides nucleiques et polypeptides

Country Status (1)

Country Link
WO (1) WO2004087874A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2141235B1 (fr) 2002-12-29 2014-06-11 Toudai Tlo, Ltd. Récepteur de l'adiponectine et gène codant pour ce récepteur
US7435808B2 (en) 2003-06-25 2008-10-14 Bristol-Myers Squibb Company Polynucleotides encoding novel adiponectin receptor variant, AdipoR2v2
EP2311468B1 (fr) * 2003-08-08 2014-01-15 Perseus Proteomics Inc. Gène surexprimé dans le cancer
US20070037204A1 (en) 2003-08-08 2007-02-15 Hiroyuki ABURANTAI Gene overexpressed in cancer
US20060008876A1 (en) 2004-07-07 2006-01-12 Shami A S E ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
US7638128B2 (en) * 2005-08-19 2009-12-29 The Brigham And Women's Hospital, Inc. Method of enhancing cardiac tissue repair by administering a SFRP polypeptide
GB0523373D0 (en) * 2005-11-16 2005-12-28 Ares Trading Sa Nidogen/snep-like molecule
WO2007100684A2 (fr) * 2006-02-24 2007-09-07 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Gènes modificateurs de la matrice extracellulaire/de métastase pour la prévention ou l'inhibition de la métastase ou de la croissance tumorale et pour la caractérisation d'une tumeur
AU2007262635B2 (en) 2006-06-23 2014-09-11 Adc Therapeutics Sa Polynucleotides and polypeptide sequences involved in cancer
NZ583474A (en) 2007-09-07 2011-07-29 Univ Zuerich Method for assaying sepsis in humans by determining levels of pancreatic stone protein
FI20080326A0 (fi) 2008-04-30 2008-04-30 Licentia Oy Neurotroofinen tekijä MANF ja sen käytöt
CN104829714A (zh) 2008-11-03 2015-08-12 阿莱斯亚生物疗法股份有限公司 特异性地阻滞肿瘤抗原的生物活性的抗体
GB0904382D0 (en) * 2009-03-13 2009-04-29 Univ Dundee Treatment of cell proliferation and differentiation disorders
US10288617B2 (en) 2009-10-26 2019-05-14 Externautics Spa Ovary tumor markers and methods of use thereof
WO2011051276A1 (fr) * 2009-10-26 2011-05-05 Externautics S.P.A. Marqueurs de tumeurs du rectum et du côlon, et leurs méthodes d'utilisation
WO2011051271A2 (fr) 2009-10-26 2011-05-05 Externautics S.P.A. Marqueurs de tumeur de la prostate et méthodes d'utilisation
SMT201900505T1 (it) 2011-03-31 2019-11-13 Adc Therapeutics Sa Anticorpi contro l'antigene 1 associato ai reni e loro frammenti leganti l'antigene
PT2802351T (pt) 2012-01-09 2019-06-27 Adc Therapeutics Sa Agentes para o tratamento de cancro da mama triplo negativo
JP7280640B2 (ja) * 2018-11-14 2023-05-24 イファ ユニバーシティ-インダストリー コラボレーション ファウンデーション 動脈硬化重症度診断マーカーおよびこれを利用した診断方法

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 10 May 2002 (2002-05-10), NAGASE ET AL: "Homo sapiens mRNA for KIAA1741 protein, partial cds. .", XP002994766, Database accession no. (AB051528) *
DATABASE GENBANK [online] 16 April 2002 (2002-04-16), SHI ET AL: "EST007 Human SW480 Lanbda gt11 cDNA library Homo sapiens cDNA, mRNA sequence.", XP002994770, Database accession no. (BQ103854) *
DATABASE GENBANK [online] 19 April 2002 (2002-04-19), SEIMIYA ET AL: "Homo sapiens 182 kda tankyrase 1-binding protein (TAB182)mRNA, complete cds.", XP002994768, Database accession no. (AF441771) *
DATABASE GENESEQ [online] 18 December 2003 (2003-12-18), TANG ET AL: "Human novel cDNA sequence.", XP002994769, Database accession no. (ADC29925) *

Also Published As

Publication number Publication date
WO2004087874A2 (fr) 2004-10-14

Similar Documents

Publication Publication Date Title
WO2004080148A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2003054152A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2003025148A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002070539A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2003023013A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002081731A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2001075067A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2001057188A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2001057190A3 (fr) Acides nucleiques et polypeptides
WO2002022660A3 (fr) Noveaux acides nucleiques et polypeptides
WO2001066689A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002031111A3 (fr) Acides nucleiques et polypeptides
WO2001088088A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002059260A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2001053312A8 (fr) Nouveaux acides nucleiques et polypeptides
WO2001053455A3 (fr) Nouveaux acides nucleiques et polypeptides associes
WO2004009834A3 (fr) Nouveaux acides nucleiques et polypeptides secretes
WO2003029271A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2004087874A3 (fr) Acides nucleiques et polypeptides
WO2003011115A3 (fr) Agents de contraste multimères ciblés à base de peptides
WO2004061080A3 (fr) Polypeptides lies au stress et utilisation desdits polypeptides
WO2005047459A3 (fr) Acides nucleiques du sars, proteines, anticorps et utilisations associees
WO2001079449A3 (fr) Acides nucleiques et polypeptides nouveaux
WO2002018424A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2003080795A3 (fr) Nouveaux acides nucléiques et polypeptides sécrétés

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase